Rituxan (rituximab) - Roche
Immune Thrombotic Thrombocytopenic Purpura Presenting as an Acute Stroke Mimic in a Young Pakistani Man. (PubMed, Cureus) - Sep 15, 2026 - "The patient was treated with therapeutic plasma exchange daily, high-dose methylprednisolone, and rituximab...Neurological recovery was quick, with resolution of the right-sided weakness by the fourth hospital day and an NIHSS score of 0. This case highlights that in young patients with stroke-like presentation, severe thrombocytopenia, and microangiopathic hemolytic anemia, prompt plasma exchange and immunosuppression can be lifesaving and should be considered in iTTP." 
Journal • Cardiovascular • CNS Disorders • Epilepsy • Hematological Disorders • Ischemic stroke • Thrombocytopenia • Thrombocytopenic Purpura • HP
http://www.ncbi.nlm.nih.gov/pubmed/42733901
 
Abubakr Saaid; Deeb Kayed; Mahmoud Marashi; Muhammad Abbas; Paddy Kilian; Zyad Saeed
 
Sep 15, 2026
 
Prev Next